https://www.selleckchem.com/MEK.html
CDD-97, however, synergizes poorly with β-lactam antibiotics to inhibit the growth of bacteria expressing OXA-48 due to poor accumulation into E. coli. Despite the low in vivo activity, CDD-97 provides new insights into OXA-48 inhibition and demonstrates the potential of using DNA-encoded chemistry technology to rapidly identify β-lactamase binders and to study β-lactamase inhibition, leading to clinically useful inhibitors.Various genomic DNA sequences including a MYC promoter sequence are amenable to the formation of a G-quadruplex featuring a sna
Like
Comment
Share
